Convergence Forum | Chatham, MA

life sciences/healthcare sector

Launched in 2004, the Convergence Forum brings together high-level healthcare players to discuss and debate the most pressing topics of interest to the industry - topics like forging strong corporate partnerships; attracting funding from private and public sources; building successful research organizations; streamlining product development and approval; understanding the coming convergence of biology, software, and medical devices; and staying ahead of regulatory and reimbursement status quo.

Speakers have included CEOs and senior executives from Sanofi Genzyme, Biogen Idec, GlaxoSmithKline, Pfizer, Alnylam Pharmaceuticals, Boston Scientific, Shire, Novartis, and ABIOMED, as well as academic researchers from Harvard, MIT, Tufts, and the Broad Institute.  More information...